Daniel Dowd
About Daniel Dowd
Daniel Dowd serves as the Vice President of Medical Affairs at Genomind, where he focuses on medical education, gene research, and product development for mental healthcare. He holds a PharmD and has extensive experience in pharmacogenetics and mental health outcomes.
Work at Genomind
Daniel Dowd serves as the Vice President of Medical Affairs at Genomind, a position he has held since 2015. In this role, he oversees medical education, gene research, and product development focused on psychiatric symptomatology and treatment. His work involves the development and testing of technological platforms designed to enhance the delivery of mental healthcare. Dowd's leadership contributes to advancing the company's mission to improve mental health outcomes through innovative approaches.
Education and Expertise
Daniel Dowd earned his PharmD from the Ernest Mario School of Pharmacy at Rutgers University, completing his studies from 1999 to 2004. He also holds a Bachelor of Science degree in Biology from Binghamton University, which he obtained from 1994 to 1998. Additionally, he has achieved PGx certification through Albany College of Pharmacy and Health Sciences. His educational background provides a strong foundation for his expertise in pharmacogenetics and mental health.
Background
Daniel Dowd completed his high school education at Port Richmond High School, where he received a Regents Diploma from 1990 to 1994. Following high school, he pursued higher education, culminating in his PharmD and a BS in Biology. Prior to his current role at Genomind, he worked as a Pharmacy District Manager at Rite Aid from 2011 to 2015, overseeing operations in the Brooklyn and Queens areas.
Achievements
During his career, Daniel Dowd has collaborated with key opinion leaders to advance best practices in pharmacogenetics. He has initiated and monitored pharmacogenetic trials aimed at improving mental health outcomes. His efforts in these areas reflect his commitment to enhancing the understanding and treatment of psychiatric conditions through scientific research and collaboration.